Envisia Therapeutics - Drug Deliver Assets' Unit Acquisition

Envisia Therapeutics - Drug Deliver Assets raised a round of funding on October 05, 2017. Investors include Aerie Pharmaceuticals.

Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powe…

Articles about Envisia Therapeutics - Drug Deliver Assets' Unit Acquisition: